312 related articles for article (PubMed ID: 11506246)
1. Prospective randomized controlled multicenter trial on steroids plus ramipril in proteinuric IgA nephropathy.
Manno C; Gesualdo L; D'Altri C; Rossini M; Grandaliano G; Schena FP
J Nephrol; 2001; 14(4):248-52. PubMed ID: 11506246
[TBL] [Abstract][Full Text] [Related]
2. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
Manno C; Torres DD; Rossini M; Pesce F; Schena FP
Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
[TBL] [Abstract][Full Text] [Related]
3. Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy.
Trimarchi H; Muryan A; Young P; Forrester M; Iotti A; Pereyra H; Lombi F; Seminario O; Alonso M; Iotti R
Medicina (B Aires); 2007; 67(5):445-50. PubMed ID: 18051227
[TBL] [Abstract][Full Text] [Related]
4. [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review].
Pozzi C; Del Vecchio L; Locatelli F
G Ital Nefrol; 2002; 19(5):523-8. PubMed ID: 12439840
[TBL] [Abstract][Full Text] [Related]
5. Combined treatment with steroids and azathioprine in IgA nephropathy: design of a prospective randomised multicentre trial.
Locatelli F; Pozzi C; Del Vecchio L; Andrulli S; Pani A; Fogazzi G; Altieri P; Ponticelli C
J Nephrol; 1999; 12(5):308-11. PubMed ID: 10630693
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.
Lv J; Zhang H; Chen Y; Li G; Jiang L; Singh AK; Wang H
Am J Kidney Dis; 2009 Jan; 53(1):26-32. PubMed ID: 18930568
[TBL] [Abstract][Full Text] [Related]
7. IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine.
Pozzi C; Andrulli S; Pani A; Scaini P; Roccatello D; Fogazzi G; Pecchini P; Rustichelli R; Finocchiaro P; Del Vecchio L; Locatelli F
J Nephrol; 2013; 26(1):86-93. PubMed ID: 22460183
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of angiotensin converting enzyme inhibitor and calcium channel blocker in the treatment of steroid-resistant idiopathic nephrotic syndrome.
Kumar NS; Singh AK; Mishra RN; Prakash J
J Assoc Physicians India; 2004 Jun; 52():454-8. PubMed ID: 15645954
[TBL] [Abstract][Full Text] [Related]
9. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
Lancet; 1997 Jun; 349(9069):1857-63. PubMed ID: 9217756
[TBL] [Abstract][Full Text] [Related]
10. IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria.
Coppo R; Peruzzi L; Amore A; Piccoli A; Cochat P; Stone R; Kirschstein M; Linné T
J Am Soc Nephrol; 2007 Jun; 18(6):1880-8. PubMed ID: 17513327
[TBL] [Abstract][Full Text] [Related]
11. Clinical trial to evaluate omega-3 fatty acids and alternate day prednisone in patients with IgA nephropathy: report from the Southwest Pediatric Nephrology Study Group.
Hogg RJ; Lee J; Nardelli N; Julian BA; Cattran D; Waldo B; Wyatt R; Jennette JC; Sibley R; Hyland K; Fitzgibbons L; Hirschman G; Donadio JV; Holub BJ;
Clin J Am Soc Nephrol; 2006 May; 1(3):467-74. PubMed ID: 17699247
[TBL] [Abstract][Full Text] [Related]
12. Aldosterone breakthrough during therapy with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in proteinuric patients with immunoglobulin A nephropathy.
Horita Y; Taura K; Taguchi T; Furusu A; Kohno S
Nephrology (Carlton); 2006 Oct; 11(5):462-6. PubMed ID: 17014562
[TBL] [Abstract][Full Text] [Related]
13. Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study.
Li PK; Leung CB; Chow KM; Cheng YL; Fung SK; Mak SK; Tang AW; Wong TY; Yung CY; Yung JC; Yu AW; Szeto CC;
Am J Kidney Dis; 2006 May; 47(5):751-60. PubMed ID: 16632013
[TBL] [Abstract][Full Text] [Related]
14. Treatment of IgA nephropathy with angiotensin converting enzyme inhibitors: design of a prospective randomized multicenter trial.
Coppo R; Chiesa M; Peruzzi L; Amore A
J Nephrol; 2001; 14(6):447-52. PubMed ID: 11783600
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
Moriyama T; Honda K; Nitta K; Yumura W; Nihei H
Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
[TBL] [Abstract][Full Text] [Related]
16. Additive antiproteinuric effect of combination therapy with ACE inhibitor and angiotensin II receptor antagonist: differential short-term response between IgA nephropathy and diabetic nephropathy.
Kim MJ; Song JH; Suh JH; Lee SW; Kim GA
Yonsei Med J; 2003 Jun; 44(3):463-72. PubMed ID: 12833584
[TBL] [Abstract][Full Text] [Related]
17. Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study)*.
Schrader J; Lüders S; Kulschewski A; Hammersen F; Züchner C; Venneklaas U; Schrandt G; Schnieders M; Rangoonwala B; Berger J; Dominiak P; Zidek W;
J Hypertens; 2006 Mar; 24(3):541-8. PubMed ID: 16467658
[TBL] [Abstract][Full Text] [Related]
18. The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy.
Song JH; Lee SW; Suh JH; Kim ES; Hong SB; Kim KA; Kim MJ
Clin Nephrol; 2003 Nov; 60(5):318-26. PubMed ID: 14640237
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of IgA nephropathy with chronic renal failure].
Pozzi C
G Ital Nefrol; 2008; 25 Suppl 44():83-7. PubMed ID: 19048591
[TBL] [Abstract][Full Text] [Related]
20. Verapamil versus amlodipine in proteinuric non-diabetic nephropathies treated with trandolapril (VVANNTT study): design of a prospective randomized multicenter trial.
Boero R; Rollino C; Massara C; Vagelli G; Gonella M; Berto IM; Bajardi P; Perosa P; Malcangi U; Giorgi MP; Ghezzi PM; Borzumati M; Baroni AM; Cogno C; Triolo G; Angelini D; Antonelli A; Quarello F
J Nephrol; 2001; 14(1):15-8. PubMed ID: 11281338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
